Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort
about
Obesity: physiologic changes and implications for preoperative managementCoordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primatesInflammation in nonalcoholic steatohepatitis.Nonalcoholic fatty liver disease: Diagnostic biomarkers.Protective effects of Spirulina maxima on hyperlipidemia and oxidative-stress induced by lead acetate in the liver and kidneyClinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American SocDevelopment of diet-induced fatty liver disease in the aging mouse is suppressed by brief daily exposure to low-magnitude mechanical signals.Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesityReduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy"Genome-wide analysis of hepatic lipid content in extreme obesitySerum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional studyUtilization of dietary glucose in the metabolic syndromePrevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors.Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study.Retinol binding protein 4 correlates with and is an early predictor of carotid atherosclerosis in type 2 diabetes mellitus patients.Fish oil -- how does it reduce plasma triglycerides?Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obeseDietary fructose in nonalcoholic fatty liver disease.Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review.Obesity and Liver Cancer.Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review.Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice.The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.Retinol binding protein 4 and fatty liver: A direct link?Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations.Characteristics of patients with the "malignant obesity hypoventilation syndrome" admitted to an ICU.Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study.Immediate Metabolic Response Following Sleeve Gastrectomy in Obese Diabetics.Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease.Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American SocNonalcoholic Fatty Liver Disease in Morbidly Obese Subjects: Correlation Among Histopathologic Findings, Biochemical Features, and Ultrasound Evaluation
P2860
Q26830911-D1F335A1-2924-4E43-8758-FE40A8795275Q28478084-5CA79D9B-1779-40BE-ABCC-5305CF7BC9A6Q30453231-0798BE02-B223-4144-8DA1-00915241EE3BQ33706254-01A31E6C-7FBB-4CD2-BB8B-E08E9BAA8FF6Q33809256-B902A35F-4A3D-445E-8814-6886489336A7Q34075016-E925A137-DBE1-4D67-8485-87BFDB9F8C6AQ34087887-11EDDAC2-F3D2-4948-8225-B70759FD3504Q35064093-10332F4F-EAD8-403E-A7D6-BC86883E1369Q35113836-FAA47018-77C8-4D6F-BDB8-772AFBAA63AEQ35190566-11C41E80-F6D3-4B11-A2E6-FF5D72AC0B14Q35209121-EF034016-F530-4FDE-82DB-F8D33C5DDF13Q35568925-61BD8B93-4E1B-4AD6-B253-7FCC39F70957Q35576565-10C3E77A-0095-4F18-A6EB-FDCDDC53689DQ35681834-CAF1716C-3386-4560-89C7-95121D5B3270Q35788887-AEE570A9-8643-4553-B0B9-75DD846C12DAQ36288910-E689473E-1D95-45E4-A965-1D502F17A343Q36325541-8A67F916-F744-4F7B-8229-8EC0A697D8FDQ36584568-ADA0C557-CA75-4B99-9881-CCA247D7DD3BQ36713843-30C95D97-6CF4-4F47-8EF6-7827FB62AB05Q38079794-CD0FAE98-E094-4780-AB61-9F2B802B9076Q38443746-10351150-CD4A-4E59-A386-F213FA167FB2Q38644618-52BC9D6B-0C9B-4479-A6CC-DBA168FFE96CQ39026668-711E2FD7-3314-4761-8E07-14ED2D4F9863Q39341139-403CA26F-6998-476B-9E47-7C43A4838306Q39734472-7A0ADE69-FBBF-4833-9171-C061C2EEFAC9Q41111925-518EAF46-9E1D-4213-A0C5-8A22AA3832F6Q41696361-B223F238-2342-4BF2-8048-C14275EF92C2Q42121489-72A81F56-4EE1-4CCA-BA0F-4EFC1A815210Q44111293-A3229861-D905-40BF-B05C-2304D873CB4EQ44975379-C1034C2D-8C3A-4C89-8C8D-C94297496AEBQ45402850-2A655941-590D-414A-9E6D-C898A06E433DQ48198369-B4074C03-EE96-4FDF-A754-077BB2763C0DQ51276156-4FB3D38B-E9F9-47AF-9328-43E664A1F986Q55668670-DA8C717C-18FC-4543-9534-4765DC459459Q57781574-C5814A20-20A3-4FA5-AF1F-800D05BADE87
P2860
Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Triglyceride levels and not ad ...... e in an obesity surgery cohort
@ast
Triglyceride levels and not ad ...... e in an obesity surgery cohort
@en
type
label
Triglyceride levels and not ad ...... e in an obesity surgery cohort
@ast
Triglyceride levels and not ad ...... e in an obesity surgery cohort
@en
prefLabel
Triglyceride levels and not ad ...... e in an obesity surgery cohort
@ast
Triglyceride levels and not ad ...... e in an obesity surgery cohort
@en
P2093
P2860
P50
P356
P1433
P1476
Triglyceride levels and not ad ...... e in an obesity surgery cohort
@en
P2093
Allison R Baker
Ariel E Feldstein
Dima L Diab
Lisa Yerian
Manjula Gupta
Philip R Schauer
Sangeeta R Kashyap
Stanley L Hazen
P2860
P304
P356
10.1038/OBY.2009.89
P577
2009-04-09T00:00:00Z